AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2012
Aug 29, 2012
33422_dirs_2012-08-29_dfdd0bd5-eedd-4959-8da5-044570fd0caa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2012-08-27
Reporting Person: Shlevin Harold H. (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-27 | Stock Options | $2.32 | A | 250000 | Acquired | 2022-08-27 | Common Stock (250000) | Direct |
Footnotes
F1: Stock options vest as follows: 50,000 shares vested on August 27, 2012, 50,000 shares will vest on December 31, 2012, 75,000 shares will vest on December 31, 2013, and 75,000 shares will vest on December 31, 2014.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21